The broad, long-term objective of this project is to enable patients with uterine fibroids (UF) to make informed decisions about management options based on the highest possible quality evidence. To help achieve this objective, we propose a multi-center registry of a geographically, racially, ethnically, and clinically diverse group of women who have received medical or surgical treatment for UF, Comparing Options for Management: Patient-centered Results for Uterine Fibroids (COMPARE-UF), designed to address the following specific aims:
AIM 1) Develop the infrastructure necessary to implement large-scale observational comparative effectiveness research (CER) studies of management options for women with UF, including (a) a governance structure, policies, and procedures conducive to collaborative research involving patients, clinicians, methodologists, and other stakeholders, (b) an experienced Research and Data Coordinating Center, and (c) nine geographically diverse Clinical Centers (CCs) representing a broad range of patients and providers.
AIM 2) Use this infrastructure to implement 3 projects addressing high-priority evidence gaps related to the effect of different management strategies on patient-centered outcomes. These include PROJECT 1: Comparing management options for symptom relief PROJECT 2: Comparing management options for preserving reproductive function PROJECT 3: Comparing effectiveness in different subpopulations.
AIM 3) Evaluate innovative methods for the design, conduct, and analysis of observational comparative effectiveness research in this population.
AIM 4) Translate research results into improved patient care, through both traditional peer-reviewed publications and collaborations with stakeholders to integrate the research findings into evidence-based patient decision making tools, clinical practice guidelines, and quality measures.
Uterine fibroids are a common problem for women, causing heavy bleeding, pain, and other problems. Many women with fibroids eventually have surgery to remove their uterus (hysterectomy). This study will try to determine how well other available treatments work compared to each other and to hysterectomy, and whether they work better for some patients than others.
|Hoffman, Sarah R; Vines, Anissa I; Halladay, Jacqueline R et al. (2018) Optimizing research in symptomatic uterine fibroids with development of a computable phenotype for use with electronic health records. Am J Obstet Gynecol 218:610.e1-610.e7|
|Laughlin-Tommaso, Shannon K; Stewart, Elizabeth A (2018) Moving Toward Individualized Medicine for Uterine Leiomyomas. Obstet Gynecol 132:961-971|
|Stewart, Elizabeth A; Lytle, Barbara L; Thomas, Laine et al. (2018) The Comparing Options for Management: PAtient-centered REsults for Uterine Fibroids (COMPARE-UF) registry: rationale and design. Am J Obstet Gynecol 219:95.e1-95.e10|
|Borah, Bijan J; Yao, Xiaoxi; Laughlin-Tommaso, Shannon K et al. (2017) Comparative Effectiveness of Uterine Leiomyoma Procedures Using a Large Insurance Claims Database. Obstet Gynecol 130:1047-1056|
|Bortoletto, Pietro; Lindsey, Jennifer L; Yuan, Liping et al. (2017) Hereditary leiomyomatosis and renal cell cancer: Cutaneous lesions & atypical fibroids. Case Rep Womens Health 15:31-34|